期刊
CIRCULATION RESEARCH
卷 112, 期 6, 页码 961-968出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.112.268623
关键词
catecholaminergic polymorphic ventricular tachycardia; disease modeling; long-QT syndrome; reprogramming
资金
- European Research Council [ERC 261053-CHD-iPS]
- German Research Foundation [La 1238/3-1/4-1, Mo 2217/1-1, Si 1747/1-1]
Induced pluripotent stem cells offer the possibility to generate patient-specific stem cell lines from individuals affected by inherited disorders. Cardiomyocytes differentiated from such patient-specific induced pluripotent stem cells lines have been used to study the pathophysiology of arrhythmogenic heart diseases, such as the long-QT syndrome or catecholaminergic polymorphic ventricular tachycardia. Testing for unwanted drug side effects or tailoring medical treatment to the specific needs of individual patients with arrhythmogenic disorders may become future applications of this emerging technology. (Circ Res. 2013;112:961-968.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据